0000899243-20-016919.txt : 20200617
0000899243-20-016919.hdr.sgml : 20200617
20200617200029
ACCESSION NUMBER: 0000899243-20-016919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gover Justin D.
CENTRAL INDEX KEY: 0001754129
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 20970962
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB24 9BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-15
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754129
Gover Justin D.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
1
1
0
0
Chief Executive Officer
Ordinary Shares
2020-06-15
4
M
0
4164
0.0013
A
458129
D
Ordinary Shares
2020-06-15
4
F
0
2076
10.23
D
456053
D
Stock Options
0.0013
2020-06-15
4
M
0
4164
0.00
D
2020-06-15
2020-06-15
Ordinary Shares
4164
0
D
Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of June 15, 2020.
Column 5 of Table I of the reporting person's form 4 filed with the SEC on March 4, 2020 includes 112,548 ordinary shares underlying RSU style share options pursuant to the Issuer's Long-Term Incentive Plan, including (i) 44,880 ordinary shares vesting automatically in two equal installments on February 26, 2021 and 2022, (ii) 51,012 ordinary shares vesting automatically in three equal installments on March 1, 2021, 2022, and 2023, and (iii) 16,656 ordinary shares vesting automatically in four equal installments on June 14, 2020, 2021, 2022, and 2023. These ordinary shares have been excluded from Column 5 of this form 4 and will be reported as each tranche is vested and automatically exercised.
Mandatory withhold to cover vested RSU style share options.
Represented by ADS.
The price reported is price per ordinary share converted from price per ADS.
/s/ Justin D. Gover
2020-06-17